Drug Approval | October 06, 2021
WHO decision on Covaxin approval next week
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
Roche is notifying healthcare professionals and patients in the US about this withdrawal. Patients being treated with Tecentriq for PD-L1-positive mTNBC should discuss their care with their healthcare provider
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Five seats reserved for Wards of COVID warriors in central MBBS admission
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
Subscribe To Our Newsletter & Stay Updated
